Study of Albumin to Reduce Inflammation Following Surgery

NCT00773110 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

232

Enrollment

OTHER

Sponsor class

Stopped Recruitment under target, Finding

Conditions

Systemic Inflammatory Response Syndrome
Cardiopulmonary Bypass

Interventions

DRUG: 20% Human albumin solution
DRUG: Gelofusin

Sponsor

Imperial College London